細胞分析市場は、2023年から2029年にかけて8.97%のCAGRで成長すると予想されています。2022年の19億米ドルから2029年には163.8億米ドルを超えると予想されています。
細胞分析は、細胞数、細胞の状態、細胞の健全性と生存率、増殖、化学物質や細胞によって引き起こされる毒性を評価し、定量化するために使用されます。基礎研究、新薬の発見と開発、臨床応用はすべて、細胞ベースのアッセイの恩恵を受けています。細胞分析では、さまざまなアッセイと技術が採用されています。細胞アッセイは、細胞ベースのアッセイとも呼ばれ、細胞の健康、生存率、増殖、移動、侵入、走化性、アポトーシス、血管新生、酸化ストレス、細胞シグナル伝達、生細胞分析を決定するための重要なツールです。
細胞分析は、学術研究室、病院、バイオテクノロジー企業、製薬会社で、幹細胞、免疫学、神経学、非侵襲的出生前診断、体外受精の研究に使用されています。さらに、慢性疾患の増加や高度な癌治療法の開発により、細胞分析の技術的進歩が促進されています。
ライフサイエンス分野における広範な研究開発(R&D)活動への政府投資の増加も、成長を促すもう 1 つの大きな要因です。バイオ医薬品およびバイオテクノロジー企業の急速な拡大やヘルスケア業界の大幅な成長などの他の要因も、市場の明るい見通しに貢献すると予想されます。
The expansion of the healthcare sector and the rise in cancer incidence are the main drivers of the market for cell analysis. Additionally, the growth of hospitals, diagnostic labs, and other facilities as well as the introduction of technologically sophisticated items all contribute to the market's expansion. However, the high cost of the cell analysis technique and the labor-intensive and complicated regulatory rules restrain market expansion. Growth prospects for the market are anticipated to be provided by an increase in government funding in the life sciences industry and the rapid expansion of the biopharmaceutical & biotechnological industries.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion) |
| Segmentation | By Platform, By Charging type, By Charging Method, By Region |
| By Product |
|
| By Process |
|
| By End-user |
|
| By Region |
|
High-throughput equipment has been developed as a result of the funding for creative research and the growing demand for analytical instruments. This technology now includes features like automation, high sensitivity, and precision, all of which help with the analysis of sparse samples. This is the result of numerous improvements.
Cell analysis technology is advancing due to the increased incidence of chronic diseases and the creation of cutting-edge cancer medicines. For instance, the American company Fluidigm Corporation recently announced the release of their REAP-seq (RNA expression and protein sequencing) technology, which will help researchers better comprehend the mechanisms underlying immune response and cancer progression.
Instrument costs have gone up due to high content screening (HCS), one of the advanced cell analysis technologies. The price and duration of any HTS approach are also directly influenced by the complexity of the targeted molecule. Therefore, only a small number of end users can access novel cell analysis solutions. But certain obstacles are somewhat limiting the market's expansion for cell analysis. These include stringent legal specifications, a shortage of qualified professionals, and expensive image analysis tools.
プロセスを実行するために必要な機器を設置するコストは、世界の細胞分析市場の成長にとってやや法外なものです。標準化の欠如は、市場の需要を静かに低下させる可能性もあります。新規プレーヤーの参入と、それらの間の競争の激化は、市場開発者にとって課題となる要因です。新製品の承認に関する厳格な規則と規制は、市場の需要を妨げています。
COVID-19パンデミックの突然の発生により、コロナウイルス感染のリスクに対抗するための効果的なワクチン、薬、検査キットを開発するためのさまざまな研究手順で細胞分析技術の使用が増加しています。進行中のCOVID-19パンデミックは、単一細胞分析市場(SCA)に利益をもたらしました。パンデミックにより、ウイルス学研究におけるSCA手法の広範な使用が促進されました。研究者は、感染患者のプロファイルをよりよく理解するために、COVID-19バイオバンクからの検体を分析し、免疫反応と感染の長期的な影響をよりよく理解しています。
Cell Analysis Market was valued at USD 17.4 Billion in 2021 and is projected to reach USD 34.96 Billion by 2029, growing at a CAGR of 8.97% from 2022 to 2029.
Key market players include Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, Thermo Fisher Scientific, and others.
The sudden outbreak of the COVID-19 pandemic has led to the adoption of cell analysis technology in research procedures for developing effective vaccines, drugs, and testing kits to combat the risk of coronavirus infection.
Based On the region, the market has been classified into North America, Europe, Asia Pacific, Middle, East and Africa, and Latin America. North America dominates the global market.
The extensive utilization of cell analysis technology across hospitals and medical research laboratories pertaining to immunology, neurology, non-invasive prenatal diagnosis, in-vitro fertilization, etc., is primarily driving the global cell analysis market.
The Cell Analysis Market is segmented based on product, process, end-user and region, global trends and forecast.
By Product market is segmented into Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, HCS Systems, and Others; by Process market is segmented into Cell Identification, Cell Viability, Cell Signaling Pathways/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Target Identification and Validation, Single-Cell Analysis, Others; by End-user market is segmented into Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Research Institutes, Cell Culture Collection Repositories, and Others.
In 2021, flow cytometry had the largest market share, by product. Due to flow cytometry's widespread use in single-cell analysis applications and its capacity to evaluate a variety of characteristics in heterogeneous samples at the single-cell level, this segment accounts for a sizeable portion of the market. In contrast, it is anticipated that the high-content screening category will expand at the quickest rate during the course of the projected period. The number of studies on cell behavior is rising, which is why the market is expanding. However, the difficulties with fluorescent lighting-related procedures for cell image collecting and analysis may limit the segment's capacity for generating income to some extent.
By Process, Cell identification had the most market share in 2021. A critical stage in numerous industrial applications, including those in the food and healthcare industries, is cell identification. Because cells are recognized based on how they respond to a particular chemical, cell identification is crucial in the drug discovery process. The single-cell analysis market is anticipated to expand at the quickest rate during the course of the projection. The segment has grown significantly in recent years thanks to single-cell analysis, which evaluates individual cells at a multi-parametric level.
By the end user, due to the widespread adoption of single-cell analysis technology in research settings, the academic and research laboratories accounted for the biggest revenue share of nearly 70.4% in 2021. The adoption of SCA has been delayed until 2021 due to the volume of ongoing scientific research using SCA methodology at numerous universities. The advancement of spatial genomics, which expedites single-cell analysis in research operations, is another significant driver boosting the sector. Additionally, in June 2022, scientists at Stony Brook University in New York created single-cell cyclic multiplex in situ tagging (CycMIST) technology, a brand-new biomedical research tool that is already dominating the market. This method helps with diagnostic and research efforts by enabling scientists to assess functional proteins in a single cell.
[caption id="attachment_14648" align="aligncenter" width="1920"]
The Cell Analysis Market key players include Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, Thermo Fisher Scientific, and others.
23 January 2023: The world's top provider of diagnostic information services, Quest Diagnostics (NYSE: DGX), and Agilent Technologies Inc. (NYSE: A) today announced a partnership. The agreement will make the Agilent Resolution ctDx FIRST liquid biopsy next-generation sequencing (NGS) test available to providers and patients across the United States.
03 February 2023: In order to run high-throughput studies without compromising sample integrity, scientists at D (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the development of a new instrument for single-cell multiomics analysis.
The Cell Analysis Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
Due to its high cancer prevalence, extensive R&D, and technological breakthroughs in cell analysis systems, North America will dominate the global market for cell analysis in the years to come. The growth of the cell analysis market in North America is also being fueled by the presence of numerous hospitals, pharmaceutical and biotechnology businesses, and academic and research institutions. Businesses and research institutions in these areas have played a vital role in doing important research on stem cells and their potential to treat fatal diseases like cancer and multiple sclerosis.
Through the projection period, the Asia Pacific region is anticipated to experience considerable growth at a CAGR of 8.97%. The rapid expansion of the pharmaceutical and biopharmaceutical industries as well as the cost-effectiveness of cell analysis services are the main forces behind regional growth. Manufacturers and researchers are working together to create cutting-edge cell analysis technologies that will improve patient care. The Cell Analysis System Market is anticipated to be driven by manufacturers' focus on growing their businesses in emerging nations.
[caption id="attachment_14649" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.